Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VM-1500A-LAI + 2NRTIs Switch Study in HIV-1
NCT05204394Phase 3Unknown
- Sponsor
- Viriom Inc
- Start
- Apr 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of depulfavirine long-acting injectable in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Viriom Inc. Status: unknown.
02
Drugs
depulfavirine long-acting injectable
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT05204394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05204394.